Abstract

AbstractSucrose esters (SE) are surfactants with potential pharmaceutical applications because of their low toxicity, biocompatibility, and excellent biodegradability. Biodegradable and biocompatible copolymeric hydrogels based on glucose-6-acrylate-1, 2, 3, 4-tetraacetate (GATA) and methacrylic acid (MAA) were designed and synthesized. Because of the growing importance of sugar-based hydrogels as drug delivery systems, these new pH-responsive glucose-containing copolymeric hydrogels were investigated for oral drug delivery. The GATA monomer was synthesized and characterized. The copolymeric hydrogel was synthesized by free-radical polymerization. Azobisisobutyronitrile (AIBN) was the free-radical initiator employed and Cubane-1, 4-dicarboxylic acid (CDA) linked to two 2-hydroxyethyl methacrylate (HEMA) group was the crosslinking agent (CA) used for hydrogel preparations. The hydrogels were characterized by differential scanning calorimetry and FT-IR. Equilibrium swelling studies were carried out in enzyme-free simulated gastric and intestinal fluids (SGF and SIF, respectively). A model drug, olsalazine [3, 3-َazobis (6-hydroxy benzoic acid)] (OSZ) an azo derivative of 5-aminosalicylic acid (5-ASA), was entrapped in these gels and the in vitro release profiles were established separately in both enzyme-free SGF and SIF. The drug release was found to be faster in SIF. The drug-release profiles indicated that amount of drug release depends on their degree of swelling and crosslinking.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call